JACKIE JOACHIM: Open Payments
NPI 1841486008 · WAUKESHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 59 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,257 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $172 |
| Neurocrine BioSciences, Inc. | 11 | $158 |
| Otsuka America Pharmaceutical, Inc. | 8 | $137 |
| Lundbeck LLC | 6 | $110 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| Collegium Pharmaceutical, Inc. | 4 | $64 |
| Almatica Pharma LLC | 2 | $38 |
| Tris Pharma Inc | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: REXULTI, VRAYLAR, INGREZZA, Auvelity, TRINTELLIX, Jornay PM, LOREEV XR, Dyanavel XR.
Industry payments across WI — which companies pay providers there.
